(KRYS) Krystal Biotech - Performance -20.4% in 12m
KRYS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
50.79%
#9 in Peer-Group
Rel. Strength
21.53%
#6050 in Stock-Universe
Total Return 12m
-20.42%
#85 in Peer-Group
Total Return 5y
228.72%
#5 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 33.0 |
| P/E Forward | 18.6 |
| High / Low | USD |
|---|---|
| 52 Week High | 213.66 USD |
| 52 Week Low | 123.36 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 73.03 |
| Buy/Sell Signal +-5 | 0.38 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: KRYS (-20.4%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.11% | 68.3% | 77.5% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.3% | -6.89% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.9% | -1.4% | 35.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
0.57% | 33% | -5.3% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.89% | -5.88% | 1.36% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 59.2% | -5.89% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.66% | 61.7% | -9.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: KRYS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for KRYS
| Total Return (including Dividends) | KRYS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 12.76% | 4.38% | 4.99% |
| 3 Months | -21.91% | 5.22% | 10.23% |
| 12 Months | -20.42% | -7.16% | 14.42% |
| 5 Years | 228.72% | -24.61% | 110.17% |
| Trend Score (consistency of price movement) | KRYS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 56.8% | 3.5% | 79.1% |
| 3 Months | -59.1% | 75.7% | 95.5% |
| 12 Months | -74.6% | -85.1% | 44.7% |
| 5 Years | 90.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th76.50 | 8.03% | 7.39% |
| 3 Month | %th17.50 | -25.78% | -29.16% |
| 12 Month | %th57.00 | -14.28% | -30.45% |
| 5 Years | %th98.50 | 336.03% | 56.40% |
FAQs
Does Krystal Biotech (KRYS) outperform the market?
No,
over the last 12 months KRYS made -20.42%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months KRYS made -21.91%, while XBI made 5.22%.
Performance Comparison KRYS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
KRYS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3% | 7.8% | -16.4% | -35% |
| US NASDAQ 100 | QQQ | -2.6% | 7.4% | -17.9% | -34% |
| German DAX 40 | DAX | -2% | 13.3% | -28% | -51% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.3% | 8.6% | -16.9% | -38% |
| Hongkong Hang Seng | HSI | -1.1% | 5.6% | -35% | -57% |
| India NIFTY 50 | INDA | -1.9% | 10.8% | -13.8% | -20% |
| Brasil Bovespa | EWZ | -5.7% | 4.8% | -39.4% | -34% |
KRYS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.9% | 7.1% | -20.7% | -47% |
| Consumer Discretionary | XLY | -4.1% | 9.9% | -9.5% | -39% |
| Consumer Staples | XLP | -3.3% | 12.9% | -15.9% | -31% |
| Energy | XLE | -3.6% | 6.7% | -11.6% | -19% |
| Financial | XLF | -3.2% | 9.2% | -19.6% | -49% |
| Health Care | XLV | -1.9% | 10.3% | -8.9% | -16% |
| Industrial | XLI | -3.9% | 8.6% | -23.2% | -44% |
| Materials | XLB | -6.1% | 7% | -20.6% | -27% |
| Real Estate | XLRE | -2.1% | 11.9% | -15% | -33% |
| Technology | XLK | -2.5% | 3.7% | -19.4% | -32% |
| Utilities | XLU | -1.7% | 13.2% | -17.7% | -43% |
| Aerospace & Defense | XAR | -3.2% | 5.2% | -34.8% | -69% |
| Biotech | XBI | -2.6% | 8.4% | -2.3% | -13% |
| Homebuilder | XHB | -7.9% | 1.1% | -10.4% | -27% |
| Retail | XRT | -5.7% | 7.3% | -11.2% | -31% |
KRYS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -3.9% | 4.08% | -7.94% | -14% |
| Natural Gas | UNG | 1.9% | 21.4% | -0.3% | -14% |
| Gold | GLD | -1.5% | 13.5% | -35.7% | -64% |
| Silver | SLV | -1.5% | 7.5% | -33.1% | -44% |
| Copper | CPER | -5.3% | 6.6% | -37% | -38% |
KRYS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.3% | 9.5% | -11.9% | -21% |
| iShares High Yield Corp. Bond | HYG | -1.5% | 10.8% | -14.5% | -31% |